Related Experiment Video
Updated: Jul 11, 2026
05:41
Synchronous Triplanar Reconstruction Integrated with Color Doppler Mapping for Precise and Rapid Localization of Thyroid Lesions
Published on: February 9, 2024
Identifying a risk profile for thyroid cancer
Laura Sterian Ward1, Elaine Cristina Morari, Janaina Luisa Leite
1Molecular Genetics of Cancer Laboratory, Department of Medicine, Head and Neck Surgery, State University of Campinas, SP, Brazil. ward@unicamp.br
Arquivos Brasileiros De Endocrinologia E Metabologia
|September 25, 2007
Summary
New diagnostic tools are needed to distinguish aggressive thyroid cancers from indolent ones. Current methods often overdiagnose silent tumors, necessitating better prediction of clinical behavior for improved patient outcomes.
Area of Science:
- Oncology
- Pathology
- Molecular Diagnostics
Background:
- Thyroid cancer diagnoses have increased due to advanced diagnostic tools.
- Many micropapillary carcinomas exhibit indolent behavior and may not progress clinically.
- Overdiagnosis of indolent thyroid cancers leads to unnecessary treatments.
Purpose of the Study:
- To identify novel tools for predicting thyroid cancer aggressiveness.
- To differentiate between clinically significant and silent thyroid tumors.
- To improve pathological diagnosis and prognostic accuracy.
Main Methods:
- Review of established clinical predictors of malignancy.
- Evaluation of patient laboratory data and imaging methods.
- Analysis of molecular markers (e.g., BRAF, GST genes, p53 polymorphisms).
- Exploration of immunocytochemical markers and chromatin fractal analysis.
Main Results:
- Molecular markers like BRAF, GST genes, and p53 polymorphisms show promise.
- Immunocytochemistry and chromatin organization analysis may enhance diagnostic specificity.
- Existing clinical predictors and newer molecular/imaging data offer potential for improved risk stratification.
Conclusions:
- There is an urgent need for improved methods to predict thyroid cancer behavior.
- New tools are essential to avoid overtreatment of indolent tumors.
- Guidelines for nodule evaluation and aggressiveness assessment are critical.
Related Concept Videos
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:20Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
01:23The Thyroid Gland
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...